Praluent

verdict damages punitive damages compensatory damages lawsuit

Pharma

Amgen owes Regeneron $407M after defeat in PCSK9 antitrust suit

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win.

Fraiser Kansteiner May 15, 2025 3:52pm

Sanofi, Regeneron clinch win in PCSK9 patent feud with Amgen

May 18, 2023 3:16pm

FDA says children age 5-11 now eligible for Regeneron's Evkeeza

Mar 22, 2023 10:39am

Amgen hits back at Sanofi, Regeneron in long-running patent feud

Mar 9, 2023 9:38am

Sanofi and Regeneron win Big Pharma support in Amgen patent feud

Feb 13, 2023 11:19am

Regeneron's Evkeeza gets priority look for use in kids with HoFH

Nov 30, 2022 11:19am